Fulgent Genetics
FLGT
158 hedge funds and large institutions have $278M invested in Fulgent Genetics in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 55 reducing their positions, and 46 closing their positions.
288% more call options, than puts
Call options by funds: $1.57M | Put options by funds: $405K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.83% less ownership
Funds ownership: 57.75% → 55.92% (-1.8%)
11% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 55
12% less funds holding
Funds holding: 179 → 158 (-21)
37% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 46
41% less capital invested
Capital invested by funds: $469M → $278M (-$191M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$13.2M |
| 2 |
RI
RTW Investments
New York
|
+$12.7M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.73M |
| 4 |
JP Morgan Chase
New York
|
+$4.56M |
| 5 |
MVP
Medina Value Partners
Los Angeles,
California
|
+$3.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$11.7M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$7.53M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.22M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$4.94M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.72M |
FLGT Hedge Fund Activity: Q1 2026 in Review
158 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2026, worth a combined $278M — down 41% from $469M a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of FLGT and 29 opened new positions — a net loss of 17 holders — while 55 trimmed existing stakes and 49 added.
The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $13.2M. The largest seller was Millennium Management, cutting an estimated $11.7M.
- 158 institutional investors held Fulgent Genetics (FLGT) as of Q1 2026, down from 179 in Q4 2025.
- Funds reported $278M of Fulgent Genetics stock for Q1 2026, down 41% quarter-over-quarter.
- 29 funds opened new Fulgent Genetics positions in Q1 2026 and 46 closed out, a net change of -17 holders.
- The largest Fulgent Genetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $13.2M added.
- The largest Fulgent Genetics seller in Q1 2026 was Millennium Management, an estimated $11.7M sold.
Based on aggregated 13F filings for Q1 2026.